Details of the Drug

General Information of Drug (ID: DMB0LLM)

• Drug Name: BLI-1100

Indication

Disease Entry	ICD 11	Status	REF
Acne vulgaris	ED80	Phase 2	[1]

• Cross-matching ID: TTD ID: D02GGG

References

• [1] ClinicalTrials.gov (NCT01815450) BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris. U.S. National Institutes of Health.